Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment

A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients

NCT00002201 ·Status: COMPLETED ·Phase: NA

Atazanavir for HIV Infected Individuals: An Early Access Program

NCT00046345 ·Status: NO_LONGER_AVAILABLE

Safety Study of Raltegravir in HIV/HCV Co-infected Patients

NCT01225705 ·Status: WITHDRAWN ·Phase: PHASE4

Atazanavir/Ritonavir Maintenance Therapy

NCT00084019 ·Status: COMPLETED ·Phase: NA

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

NCT00931463 ·Status: COMPLETED ·Phase: PHASE4

Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy

NCT00357552 ·Status: COMPLETED ·Phase: NA

Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV Patients

NCT02238314 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating the Efficacy of a Reduced Dose Atazanavir in HIV-1-infected Patients

NCT02473328 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients

NCT00838162 ·Status: COMPLETED ·Phase: PHASE2

Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection

NCT00885664 ·Status: COMPLETED ·Phase: PHASE4

Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects

NCT00096746 ·Status: COMPLETED

A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor

NCT00028067 ·Status: TERMINATED ·Phase: PHASE3

Phase IIB Pilot of Atazanavir + Raltegravir

NCT00768989 ·Status: TERMINATED ·Phase: PHASE2

Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects

NCT00357188 ·Status: COMPLETED ·Phase: PHASE1

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

NCT00654147 ·Status: COMPLETED ·Phase: PHASE2

Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure

NCT00002047 ·Status: COMPLETED ·Phase: NA

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

NCT01605084 ·Status: WITHDRAWN ·Phase: PHASE3

Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

NCT00052117 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

NCT00025727 ·Status: UNKNOWN ·Phase: PHASE3

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

NCT00027339 ·Status: COMPLETED ·Phase: PHASE2

Test Albuvirtide in Experienced Patients

NCT02369965 ·Status: COMPLETED ·Phase: PHASE3

"The Once A Day Protease Inhibitor Regimens"

NCT00242216 ·Status: COMPLETED ·Phase: PHASE4

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

NCT00028301 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

NCT00326716 ·Status: COMPLETED ·Phase: PHASE1

Early Access to Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or Early Treatment Experienced in HIV-1 Patients

NCT01702090 ·Status: COMPLETED ·Phase: PHASE4